FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SHERMYEN JOHN
2. Issuer Name and Ticker or Trading Symbol

ALMOST FAMILY INC [ AFAM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP Healthcare Innovations
(Last)          (First)          (Middle)

9510 ORMSBY STATION ROAD, SUITE 300
3. Date of Earliest Transaction (MM/DD/YYYY)

5/1/2017
(Street)

LOUISVILLE, KY 40223
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/1/2017     S    7000   D $49.50   (4) 87864   D    
Common Stock   5/15/2017     S    3000   D $56.82   (5) 84864   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)   $49.05                      (3) 3/9/2027   Common Stock   800     800   D    
Option (right to buy)   (1) $36.03                      (2) 3/3/2026   Common Stock   1100     1100   D    

Explanation of Responses:
(1)  Granted pursuant to the 2013 Stock & Incentive Compensation Plan.
(2)  The option becomes exercisable in four equal annual installments beginning on the first anniversary of the date of grant, March 4, 2016.
(3)  The option becomes exercisable in four equal annual installments beginning on the first anniversary of the date of grant, March 10, 2017.
(4)  Weighted average sales price. On 5/1/17, the 7,000 shares were sold within a range of $49.45 and $49.65. The reporting person will provide upon request by the Commission Staff, the issuer, or security holder of the issuer, full information regarding the number of shares sold at each separate price.
(5)  Weighted average sales price. On 5/15/17, the 3,000 shares were sold within a range of $56.60 and $57.10. The reporting person will provide upon request by the Commission Staff, the issuer, or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SHERMYEN JOHN
9510 ORMSBY STATION ROAD
SUITE 300
LOUISVILLE, KY 40223


SVP Healthcare Innovations

Signatures
/s/ John L. Shermyen 5/19/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Almost Family (NASDAQ:AFAM)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Almost Family Charts.
Almost Family (NASDAQ:AFAM)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Almost Family Charts.